Cryptococcosis clinical trials

The registry lists 40 studies for Cryptococcosis across more than 10 countries. 4 are recruiting or about to start. 7 of them are mainly about Cryptococcosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its narrower condition Meningitis, Cryptococcal too: 73 studies, 9 open.

Get an email when these change. Save the Cryptococcosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 29
Status unknown: 5
Not yet recruiting: 2
Recruiting: 2
Withdrawn: 1
Terminated: 1

Phase

Phase 3: 7
Phase 4: 4
Phase 2: 3
Phase 1: 1

Where

United States: 20
Uganda: 3
Canada: 3
China: 2
Japan: 2
Vietnam: 2

Who runs them

Pfizer (12) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · University of Minnesota (3) · Merck Sharp & Dohme LLC (3) · Asahi Kasei Pharma Corporation (1) · National Cancer Institute (NCI) (1) · Oxford University Clinical Research Unit, Vietnam (1) · Singh, Ranjan Kumar, M.D. (1)

What is being tested here

Drugs under test in Cryptococcosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Phase 3	All
Fluconazole	1	14
Amphotericin B	1	8
Posaconazole	2	3
Flucytosine	0	2
Itraconazole	0	1
Dexamethasone	0	1
Isavuconazole	1	1
Efavirenz	0	1
Nucleosides	0	1
Tamoxifen	0	1

Coming up

0phase 3 studies under way

1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Jun 2027Cryptococcosis Associated With Bruton Tyrosine Kinase Inhibitors · Assistance Publique - Hôpitaux de Paris

Who these studies take

Of the 2 Cryptococcosis studies recruiting now, 1 (50%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (50%) take healthy volunteers.

Recruiting studies that take each age, of 2
Age	Women	Men
10	1 (50%)	1 (50%)
18	2 (100%)	2 (100%)
30	2 (100%)	2 (100%)
40	2 (100%)	2 (100%)
50	2 (100%)	2 (100%)
65	2 (100%)	2 (100%)
75	2 (100%)	2 (100%)
85	2 (100%)	2 (100%)

Across all 40 studies, recruiting or not: 13% stop at 75 or younger and 8% at 65; 50% take children; 0% are for women only and 0% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered1

Cryptococcosis Associated With Bruton Tyrosine Kinase InhibitorsOct 19, 2026NCT07881055

Studies

Recruiting first, then most recently updated. Showing 40 of 40. search them.